Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.

Source:http://linkedlifedata.com/resource/pubmed/id/15024400

Download in:

View as

General Info

PMID
15024400